Influence of haematological parameters before coronary angioplasty on subsequent restenosis

Acta Cardiologica

Volumn 59, Issue 3, 2004, Pages 263-268

  Avci, Ahmet ^a   Boyaci, Ayca ^a,b   Çaǧli, Kerim ^a   Cosgun, Ayhan ^a   Gokce, Veli ^a   Duru, Erdal ^a   Korkmaz, Sule ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Angioplasty; Platelet size; Restenosis; Risk assesment

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROSPECTIVE STUDY; RESTENOSIS; RISK ASSESSMENT; STABLE ANGINA PECTORIS; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PLATELETS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT;

EID: 2942717114     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.59.3.2005180     Document Type: Article

References (30)

1. Lehmann KG, Gonzales E, Tri BD, Vaziri ND. Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation. Am Heart J 1999; 137: 274-83.
2. Smyth DW, Martin JF, Michalis L, Bucknall CA, Jewitt DE. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 1993; 23: 361-7.
3. Gustavsson CG, Persson S, Thorvinger BO, Hedner P. Association between pre-PTCA blood haemoglobin concentration and the risk of symptomatic restenosis after successful PTCA of primary coronary stenoses. J Cardiovasc Risk 1997; 4: 37-40.
4. Heras M, Chesebro JH, Penny WJ, Bailey KR, Lam J, Holmes DR, Reeder GS, Badimon L, Fuster V. Influence of adequate heparin dosage in arterial angioplasty in a porcine model. Circulation 1988; 78: 654-60.
5. Bienvenu JG, Tanguay JF, Chauvet P, Merhi Y. Relationship between platelets and neutrophil adhesion and neointimal growth after repeated arterial wall injury induced by angioplasty in pigs. J Vasc Res 2001; 38: 153-62.
6. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y. Fibrinogen after coronary angioplasty as a risk factor for réstenosis. Circulation 1995; 92: 31-8.
7. Symonides B, Januszewicz A, Rowinski O, Januscewicz M, Chodakowska J, Berent H, Kuczynska K, Szmigielski C, Malek G, Januszewicz W. Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis. J Cardiovasc Risk 1999; 6: 269-72.
8. Bach R, Jung F, Kohsiek I, Ozbek C, Spitzer S, Scheller B, Dyckmans J, Schieffer H. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 1994; 74 (suppl 1): S55-67.
9. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991; 17 (suppl B): 77B-88B.
10. Weintraub WS, Kosinki AS, Brow III CL, King III SB. Can restenosis after percutaneous coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993; 21: 6-14.
11. Haudenschild CC. Pathobiology of restenosis after angioplasty. Am J Med 1993; 94 (suppl 4A): 40S-44S.
12. Forrester JH, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive theraphies. J Am Coll Cardiol 1991; 17: 758-69.
13. Pizzuli L, Yang A, Martin JF, Lüderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80-4.
14. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE. Concurrent morning increase in platelet aggregability and the risk of MI and sudden cardiac death. N Engl J Med 1987; 316: 1514-8.
15. Fitzgerald DJ, Roy L, Castella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-9.
16. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PE Blood platelet count and function are related to total and cardiovascular death in appearently healthy men. Circulation 1991; 84: 613-7.
17. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of MI. N Engl J Med 1990; 322: 1549-54.
18. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell WG. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 1991; 83: 38-44.
19. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32: 443-60.
20. Haver VM, Gear ARL. Functional fractionation of platelets. J Lab Clin Med 1981; 97:187-204.
21. Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med 1986; 314: 488-500.
22. Steele PM, Chesebro JH, Stanson AW, Holmes DR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: natural history of pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-12.
23. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri RC, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1987; 75: 636-42.
24. 111indium-labelled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol 1986; 8: 1380-6.
25. Libby P, Warner SJC, Salomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma. N Engl J Med 1988; 318: 1493-8.
26. Assoian RK, Grotendorst GR, Miller DM, Sporn MB. Cellular transformation by coordinate action of three peptid growth factors from human platelets. Nature 1984; 309: 804-6.
27. Nobuyoshi M, Kimura T, Ohoshi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991; 17: 433-9.
28. Martin JF, Trowbridge EA, Salmon GL, Slater DN. The relationship between platelets and megakaryocyte volumes. Thromb Res 1982; 28: 447-59.
29. Kristensen SD, Roberts KM, Kishk YT, Martin JF. Accelerated atherogenesis occurs following platelet destruction and increases in megakaryocyte size and DNA content. Eur J Clin Invest 1990; 20: 239-47.
30. Gladwyn A-M, Martin JF. The control of megakaryocyte ploidy and platelet production: biology and pathology. Int J Cell Cloning 1990; 8: 291-8.